Peak Bio Analyst Ratings
Peak Bio Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/04/2022 | 294.74% | Ladenburg Thalmann | → $15 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 2022 年 4 月 11 日 | 294.74% | 拉登堡塔尔曼 | → 15 美元 | 启动覆盖范围开启 | → 购买 |
Peak Bio Questions & Answers
Peak Bio 问题与解答
The latest price target for Peak Bio (NASDAQ: PKBO) was reported by Ladenburg Thalmann on November 4, 2022. The analyst firm set a price target for $15.00 expecting PKBO to rise to within 12 months (a possible 294.74% upside). 1 analyst firms have reported ratings in the last year.
拉登堡·塔尔曼于2022年11月4日公布了Peak Bio（纳斯达克股票代码：PKBO）的最新目标股价。该分析公司将目标股价定为15.00美元，预计PKBO将在12个月内升至12个月内（可能上涨294.74％）。1家分析公司去年公布了评级。
The latest analyst rating for Peak Bio (NASDAQ: PKBO) was provided by Ladenburg Thalmann, and Peak Bio initiated their buy rating.
拉登堡·塔尔曼对Peak Bio（纳斯达克股票代码：PKBO）的最新分析师评级由拉登堡·塔尔曼提供，Peak Bio启动了买入评级。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Peak Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Peak Bio was filed on November 4, 2022 so you should expect the next rating to be made available sometime around November 4, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Peak Bio的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Peak Bio的最新评级是在2022年11月4日发布的，因此您应该预计下一个评级将在2023年11月4日左右公布。
While ratings are subjective and will change, the latest Peak Bio (PKBO) rating was a initiated with a price target of $0.00 to $15.00. The current price Peak Bio (PKBO) is trading at is $3.80, which is within the analyst's predicted range.
虽然评级是主观的，而且会发生变化，但最新的Peak Bio（PKBO）评级最初是以0.00美元至15.00美元的目标股价为0.00美元至15.00美元。Peak Bio（PKBO）目前的交易价格为3.80美元，在分析师的预测范围内。
译文内容由第三方软件翻译。